The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSant Uk.10te% Regulatory News (SAN)

Share Price Information for Sant Uk.10te% (SAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 147.75
Bid: 145.50
Ask: 150.00
Change: 0.00 (0.00%)
Spread: 4.50 (3.093%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 147.75
SAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Shire plc

26 Sep 2018 15:39

RNS Number : 0515C
Santander UK Plc
26 September 2018
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Santander UK Plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Shire plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

25/09/2018

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

7,643,287

0.8753

(2) Cash-settled derivatives:

 

7,643,287

0.8753

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

7,643,287

0.8753

7,643,287

0.8753

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

5p Ordinary

Sale

8,000,000

45.05 GBP

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

5p Ordinary

Total return swap

Decreasing short position

8,000,000

45.05 GBP

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

26 September 2018

Contact name:

Laura Sweeney

Telephone number:

020 7756 3767

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETBSGDCRBDBGIL
Date   Source Headline
30th Apr 20104:20 pmRNSPublication of Supplemental Prospectus
29th Apr 201011:32 amRNSPublication of a Supplementary Prospectus
29th Apr 20108:45 amRNSAdmission to listing
29th Apr 20107:30 amRNSSantander UK Quarter 1 profits up 15%
28th Apr 201012:29 pmRNSPreference Scheme becoming effective
27th Apr 20104:31 pmRNSPublication of supplemental prospectus
27th Apr 20104:30 pmRNSCourt sanction of Preference Scheme and Suspension
27th Apr 20103:00 pmRNSAnnual Financial Report - Part 2 of 2
27th Apr 20103:00 pmRNSAnnual Financial Report - Part 1 of 2
27th Apr 20101:36 pmRNSNotice to holders
27th Apr 201012:20 pmRNSNotice to holders
16th Apr 20109:57 amRNSPublication of Prospectus
30th Mar 20103:50 pmRNSResults of Meetings
18th Mar 20102:22 pmRNSPublication of final terms
15th Mar 20107:30 amRNSPosting of scheme document and prospectus
10th Mar 20103:50 pmRNSNotice of General Meeting and Result
10th Mar 20101:18 pmRNSNotice of redemption of notes
3rd Mar 20106:11 pmRNSSupplementary Prospectus
26th Feb 20107:30 amRNSAlliance & Leicester plc and Santander UK plc
26th Feb 20107:30 amRNSAlliance & Leicester plc and Santander UK plc
25th Feb 20103:00 pmRNSImportant changes to Alliance & Leicester plc
4th Feb 20107:30 amRNSFull Year Trading Statement
12th Jan 20105:14 pmRNSSupplementary Prospectus
11th Jan 20109:53 amRNSChange of Name
22nd Dec 20097:00 amRNSOFT announces decision and next steps on bank char
18th Dec 200911:36 amRNSAdoption of New Articles of Association
16th Dec 200912:51 pmRNSPublication of Prospectus
13th Nov 20093:07 pmRNSSupplemental Prospectus
2nd Nov 20095:55 pmRNSReplacement - Supplementary Prospectus
2nd Nov 20094:50 pmRNSSupplementary Prospectus
28th Oct 20094:56 pmRNSSupplementary Prospectus
28th Oct 20097:30 amRNSQ3 2009 Trading Statement
10th Sep 20091:16 pmRNSSupplemental Prospectus
28th Aug 20092:00 pmRNSHalf Yearly Report
31st Jul 20097:32 amRNSDirectorate Change
31st Jul 20097:30 amRNSDirectorate Change
29th Jul 20097:30 amRNSHalf Yearly Report
29th Jul 20097:30 amRNS2009 Half Year Trading Statement
8th Jun 200911:13 amRNSDoc re. Notice of AGM
1st Jun 200911:30 amRNSDirectorate Change
1st Jun 200911:30 amRNSDirectorate Change
29th Apr 20097:30 amRNSTrading Statement
17th Apr 20094:00 pmRNSDirectorate Change
17th Apr 20094:00 pmRNSDirectorate Change
14th Apr 20096:33 pmRNSPublication of Prospectus
1st Apr 20099:27 amRNSAnnual Information Update
27th Mar 20099:00 amRNSPublication of Prospectus
20th Mar 20097:30 amRNS2008 Annual Report and Accounts - Part 2
20th Mar 20097:30 amRNS2008 Annual Report and Accounts - Part 1
25th Feb 20096:00 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.